BioCentury
ARTICLE | Company News

Capstone Therapeutics, LipimetiX deal

August 13, 2012 7:00 AM UTC

Capstone and LipimetiX formed a 60/40 JV, LipimetiX Development LLC, to develop LipimetiX's mimetics of apolipoprotein E (APOE). LipimetiX has rights to the compounds from University of Alabama at B...